Effectiveness of WHO mhGAP-IG in identification and management of depression by primary level non-specialist health workers – A cluster randomized controlled trial in rural Karnataka and Maharashtra
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 2027
Project Lead
Uttara Chari
Authors
Uttara Chari
Project Status
ongoing
Project Type
Funded - ICMR